Urine Metabolites in the Diagnosis of Disease | MicrobiomeTrials← Back to trialsNCT06710067
Urine Metabolites in the Diagnosis of Disease
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-10-01Est. Completion: 2025-09
Enrollment target: 1,250 participants Locations- Unio Health Partners (Gastroenterology), Encinitas, California, United States
- Digestive Health Associates, Santa Monica, California, United States
- Westside Gastro Care, Santa Monica, California, United States
- Bass Medical Group (Gastroenterology), Walnut Creek, California, United States
Other microbiome trials you might be interested in
CRC (Colorectal Cancer)
Efficacy and safety of retlirafusp alfa combined with bevacizumab and chemotherapy with or without short-course radiothe…
Wuhan, ChinaEst. completion Jun 30, 2029
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated CarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Mucinous Adenocarcinoma
Endometrial Undifferentiated Carcinoma
Endometrioid Adenocarcinoma
Recurrent Endometrial Carcinoma
This phase II trial tests whether the combination of nivolumab and ipilimumab is better than nivolumab alone to shrink t…
Birmingham, United StatesEst. completion Jul 30, 2032
Advanced/Metastatic Solid Tumors
This is a multicenter, open-label, multiple-dose, FIH Phase 1a/1b study. Phase 1a adopts an accelerated titration design…
Los Angeles, United StatesEst. completion Jun 2028